Paolo Tarantino: So much going on in the ADC field.
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared the following on Twitter:
“So much going on in the ADC field. Positive press releases, combo trials, multiple new approvals each year, and the first histology-agnostic indication on the horizon.
Yet, much remains to be unveiled on how ADCs work and how to mitigate their toxicities, that too often resemble traditional chemotherapy.
Today I had the honor of discussing these topics with an outstanding panel at the AACR-NCI-EORTC “Triple Meeting”, contributing with a lecture on Optimizing the Toxicites of ADCs, learning from brilliant lectures by Raffaele Colombo & Anthony Tolcher and from the outstanding chairing by Patricia LoRusso & Elisabeth de Vries.”
Source: Paolo Tarantino/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023